TaiMed Biologics (4147) — Strategic Asset Allocation Index
TaiMed Biologics (4147) has a Strategic Asset Allocation Index of 35.1% as of June 2023. Strategic assets (PP&E of NT$930.02 Million plus long-term investments of NT$-) total NT$930.02 Million, measured against net assets of NT$2.65 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See TaiMed Biologics (4147) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
TaiMed Biologics Strategic Asset Allocation Index (2009–2022)
This chart shows how TaiMed Biologics's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2022. As of June 2023, the index stands at 35.1%, representing strategic assets of NT$930.02 Million against net assets of NT$2.65 Billion TWD. For live market cap and overall valuation, see how much is TaiMed Biologics worth.
Annual Strategic Asset Allocation Index for TaiMed Biologics (2009–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for TaiMed Biologics from 2009 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 4147 book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 35.3% | NT$957.74 Million | NT$957.74 Million | NT$- | NT$2.71 Billion | ▲ +0.9 pp |
| 2021 | 34.4% | NT$1.01 Billion | NT$1.01 Billion | NT$- | NT$2.94 Billion | ▲ +3.2 pp |
| 2020 | 31.2% | NT$1.06 Billion | NT$1.06 Billion | NT$- | NT$3.42 Billion | ▼ -2.0 pp |
| 2019 | 33.2% | NT$1.19 Billion | NT$940.32 Million | NT$249.36 Million | NT$3.59 Billion | ▲ +0.7 pp |
| 2018 | 32.5% | NT$1.33 Billion | NT$863.18 Million | NT$462.53 Million | NT$4.08 Billion | ▲ +21.3 pp |
| 2017 | 11.2% | NT$479.34 Million | NT$315.09 Million | NT$164.25 Million | NT$4.29 Billion | ▲ +10.5 pp |
| 2016 | 0.6% | NT$29.27 Million | NT$19.27 Million | NT$10.00 Million | NT$4.71 Billion | ▲ +0.3 pp |
| 2015 | 0.3% | NT$15.99 Million | NT$15.99 Million | NT$- | NT$4.90 Billion | ▼ -0.6 pp |
| 2014 | 0.9% | NT$16.21 Million | NT$16.21 Million | NT$- | NT$1.83 Billion | ▲ +0.4 pp |
| 2013 | 0.5% | NT$3.17 Million | NT$3.17 Million | NT$- | NT$657.73 Million | ▼ -0.3 pp |
| 2012 | 0.8% | NT$4.84 Million | NT$4.84 Million | NT$- | NT$645.21 Million | ▲ +0.2 pp |
| 2011 | 0.5% | NT$4.25 Million | NT$4.25 Million | NT$- | NT$839.24 Million | ▼ 0.0 pp |
| 2010 | 0.5% | NT$5.45 Million | NT$5.45 Million | NT$- | NT$1.04 Billion | ▼ -0.5 pp |
| 2009 | 1.0% | NT$6.06 Million | NT$6.06 Million | NT$- | NT$598.14 Million | — |